Tc-99m albumin scintigraphy to monitor the effect of treatment in protein-losing gastroenteropathy.
OBJECTIVE
Tc-99m albumin scintigraphy is a noninvasive method for detecting protein-losing gastroenteropathy.


METHODS
Seven patients with protein-losing gastroenteropathy were evaluated with Tc-99m albumin scintigraphy. In addition, Tc-99m albumin scintigraphy was used to monitor the effect of treatment in five of these seven patients. The scintigraphic results were compared with serum albumin levels.


RESULTS
All seven patients had positive results in the pretreatment images. Changes in scintigraphic findings in the five treated patients correlated well with changes in serum albumin level.


CONCLUSIONS
Tc-99m albumin scintigraphy is useful not only for diagnosing protein-losing gastroenteropathy but also for monitoring the effect of treatment.
Wang
S J
SJ
Department of Nuclear Medicine, Taichung Veterans General Hospital, Taiwan, Republic of China.
Tsai
S C
SC
Lan
J L
JL
D000328:Adult; D004064:Digestive System / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011504:Protein-Losing Enteropathies / Q000097:blood / Q000000981:diagnostic imaging* / Q000628:therapy; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012709:Serum Albumin / Q000032:analysis; D013668:Technetium Tc 99m Aggregated Albumin
D019275:Radiopharmaceuticals; D012709:Serum Albumin; D013668:Technetium Tc 99m Aggregated Albumin